International Congress Amsterdam 2015

Saturday, 26.09.2015 Sunday, 27.09.2015 Monday, 28.09.2015 Tuesday, 29.09.2015 Wednesday, 30.09.2015		Sponsored symposia: Evening Symposium organised by Novartis Pharma AG: "IgE-mediated asthma: New revelations and future insights" Evening Symposium organised by Boehringer Ingelheim International GmbH: "The challenge of treating uncontrolled asthma on Step 3 and higher: Comparing options" Industry early morning symposium organised by Novartis Pharma AG: "Multidisciplinary approaches in the personalized care of the ALK + NSCLC patient"

Citations should be made in the following way: Authors. Title. Eur Respir J 2015; 46: Suppl. 59, abstract number.

Asthma: emerging risk factors and current management of the patient

Lunchtime session
Chairs: Maria Gabriela Belvisi (London, United Kingdom), Ian Douglas Pavord (Oxford, United Kingdom)
Aims: To learn about the latest treatments, clinical developments and thinking in the areas of asthma risk, management and treatment.
Target audience: The session will be most relevant for practicing clinicians, including respiratory physicians and paediatricians, but it will also be relevant for epidemiologists and translational scientists.

Download all media

Known and emerging risk factors for asthma development: is prevention possible? Richard Beasley (Wellington, New Zealand)
Targeting the interleukin pathway in the treatment of asthma Kian Fan Chung (London, United Kingdom)
Novel insights into the genetics of smoking behaviour, lung function and chronic obstructive pulmonary disease in UK Biobank Ian P. Hall (Nottingham, United Kingdom)